MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejca.2022.11.007

Медицинская библиотека · European journal of cancer (Oxford, England : 1990) · 2022

Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.

Jiao Yue, Truong Thérèse, Eon-Marchais Séverine, Mebirouk Noura, Caputo Sandrine M, Dondon Marie-Gabrielle, Karimi Mojgan, Le Gal Dorothée, Beauvallet Juana, Le Floch Édith, Dandine-Roulland Claire, Bacq-Daian Delphine, Olaso Robert, Albuisson Juliette, Audebert-Bellanger Séverine, Berthet Pascaline, Bonadona Valérie, Buecher Bruno, Caron Olivier, Cavaillé Mathias, Chiesa Jean, Colas Chrystelle, Collonge-Rame Marie-Agnès, Coupier Isabelle, Delnatte Capucine, De Pauw Antoine, Dreyfus Hélène, Fert-Ferrer Sandra, Gauthier-Villars Marion, Gesta Paul, Giraud Sophie, Gladieff Laurence, Golmard Lisa, Lasset Christine, Lejeune-Dumoulin Sophie, Léoné Mélanie, Limacher Jean-Marc, Lortholary Alain, Luporsi Élisabeth, Mari Véronique, Maugard Christine M, Mortemousque Isabelle, Mouret-Fourme Emmanuelle, Nambot Sophie, Noguès Catherine, Popovici Cornel, Prieur Fabienne, Pujol Pascal, Sevenet Nicolas, Sobol Hagay, Toulas Christine, Uhrhammer Nancy, Vaur Dominique, Venat Laurence, Boland-Augé Anne, Guénel Pascal, Deleuze Jean-François, Stoppa-Lyonnet Dominique, Andrieu Nadine, Lesueur Fabienne

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Three partially overlapping breast cancer polygenic risk scores (PRS) comprising 77, 179 and 313 SNPs have been proposed for European-ancestry women by the Breast Cancer Association Consortium (BCAC) for improving risk prediction in the general population. However, the effect of these SNPs may vary from one country to another and within a country because of other factors.

OBJECTIVE

To assess their associated risk and predictive performance in French women from (1) the CECILE population-based case-control study, (2) BRCA1 or BRCA2 (BRCA1/2) pathogenic variant (PV) carriers from the GEMO study, and (3) familial breast cancer cases with no BRCA1/2 PV and unrelated controls from the GENESIS study.

RESULTS

All three PRS were associated with breast cancer in all studies, with odds ratios per standard deviation varying from 1.7 to 2.0 in CECILE and GENESIS, and hazard ratios varying from 1.1 to 1.4 in GEMO. The predictive performance of PRS313 in CECILE was similar to that reported in BCAC but lower than that in GENESIS (area under the receiver operating characteristic curve (AUC) = 0.67 and 0.75, respectively). PRS were less performant in BRCA2 and BRCA1 PV carriers (AUC = 0.58 and 0.54 respectively).

CONCLUSION

Our results are in line with previous validation studies in the general population and in BRCA1/2 PV carriers. Additionally, we showed that PRS may be of clinical utility for women with a strong family history of breast cancer and no BRCA1/2 PV, and for those carrying a predicted PV in a moderate-risk gene like ATM, CHEK2 or PALB2.

Для цитирования: Jiao Yue, Truong Thérèse, Eon-Marchais Séverine, Mebirouk Noura, Caputo Sandrine M, Dondon Marie-Gabrielle, Karimi Mojgan, Le Gal Dorothée, Beauvallet Juana, Le Floch Édith, Dandine-Roulland Claire, Bacq-Daian Delphine, Olaso Robert, Albuisson Juliette, Audebert-Bellanger Séverine, Berthet Pascaline, Bonadona Valérie, Buecher Bruno, Caron Olivier, Cavaillé Mathias, Chiesa Jean, Colas Chrystelle, Collonge-Rame Marie-Agnès, Coupier Isabelle, Delnatte Capucine, De Pauw Antoine, Dreyfus Hélène, Fert-Ferrer Sandra, Gauthier-Villars Marion, Gesta Paul, Giraud Sophie, Gladieff Laurence, Golmard Lisa, Lasset Christine, Lejeune-Dumoulin Sophie, Léoné Mélanie, Limacher Jean-Marc, Lortholary Alain, Luporsi Élisabeth, Mari Véronique, Maugard Christine M, Mortemousque Isabelle, Mouret-Fourme Emmanuelle, Nambot Sophie, Noguès Catherine, Popovici Cornel, Prieur Fabienne, Pujol Pascal, Sevenet Nicolas, Sobol Hagay, Toulas Christine, Uhrhammer Nancy, Vaur Dominique, Venat Laurence, Boland-Augé Anne, Guénel Pascal, Deleuze Jean-François, Stoppa-Lyonnet Dominique, Andrieu Nadine, Lesueur Fabienne. Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease.. European journal of cancer (Oxford, England : 1990). 2022. DOI: 10.1016/j.ejca.2022.11.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.